Angioimmunoblastic
T-Cell Lymphoma
Treatment Options
Patients with AITL may be treated with a steroid that can temporarily relieve the symptoms caused by the immune system’s reaction to the cancer cells, such as joint inflammation or pain and skin rash.
Recommended first-line therapy is either a clinical trial or a multiagent chemotherapy regimen, such as CHOP (cyclophosphamide doxorubicin, vincristine, and prednisone). Sometimes higher doses of chemotherapy followed by stem cell transplantation may be added to multiagent chemotherapy.
Several drugs have been tested in small clinical trials (alone or in combination with current chemotherapy regimens) and show promise for the treatment of AITL, including:
- Brentuximab vedotin (Adcetris)
- Lenalidomide (Revlimid)
- Panobinostat (Farydak)
Learn More
To learn more about AITL, view the T-Cell Lymphomas Guide. Want to talk to someone? For answers to lymphoma-related questions and resources, contact our Lymphoma Resource Center at (800) 500-9976 or [email protected].
Additional Resources
To learn more about AITL, view the T-Cell Lymphomas Guide.
Events
Events
-
-
Pregunte al doctor sobre el linfoma
Descripción general del programa Este programa proporciona a los pacientes recién diagnosticados una base sólida […]
-
Ask the Doctor About Lymphoma: Navigating Relapsed/Refractory Disease
Program Overview This program will provide patients with information on what to consider if their […]